Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanoparticle technology for treatment of Parkinson's disease: the role of surface phenomena in reaching the brain
Gerardo Leyva‐Gómez, Hernán Cortés, Jonathan J. Magaña, et al.
Drug Discovery Today (2015) Vol. 20, Iss. 7, pp. 824-837
Closed Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases
Miguel Chin-Chan, Juliana Navarro-Yepes, Betzabet Quintanilla‐Vega
Frontiers in Cellular Neuroscience (2015) Vol. 9
Open Access | Times Cited: 591
Nano carriers for drug transport across the blood–brain barrier
Xinming Li, John Tsibouklis, Tingting Weng, et al.
Journal of drug targeting (2016) Vol. 25, Iss. 1, pp. 17-28
Open Access | Times Cited: 237
Stimuli-responsive In situ gelling system for nose-to-brain drug delivery
Mukta Agrawal, Shailendra Saraf, Swarnlata Saraf, et al.
Journal of Controlled Release (2020) Vol. 327, pp. 235-265
Closed Access | Times Cited: 204
Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson’s disease treatment
Chenchen Bi, Aiping Wang, Yongchao Chu, et al.
International Journal of Nanomedicine (2016) Vol. Volume 11, pp. 6547-6559
Open Access | Times Cited: 171
The protein corona and its effects on nanoparticle-based drug delivery systems
Hanmei Li, Yao Wang, Qi Tang, et al.
Acta Biomaterialia (2021) Vol. 129, pp. 57-72
Closed Access | Times Cited: 156
Non-Ionic Surfactants for Stabilization of Polymeric Nanoparticles for Biomedical Uses
Hernán Cortés, Héctor Hernández‐Parra, Sergio A. Bernal-Chávez, et al.
Materials (2021) Vol. 14, Iss. 12, pp. 3197-3197
Open Access | Times Cited: 155
Nanocarriers for targeted drug delivery
Afzal Shah, Saima Aftab, Jan Nisar, et al.
Journal of Drug Delivery Science and Technology (2021) Vol. 62, pp. 102426-102426
Closed Access | Times Cited: 130
Neuroprotective Effects of Curcumin in Neurodegenerative Diseases
Giuseppe Genchi, Graziantonio Lauria, Alessia Catalano, et al.
Foods (2024) Vol. 13, Iss. 11, pp. 1774-1774
Open Access | Times Cited: 18
Poly(trehalose) Nanoparticles Prevent Amyloid Aggregation and Suppress Polyglutamine Aggregation in a Huntington’s Disease Model Mouse
Koushik Debnath, Nibedita Pradhan, Brijesh Kumar Singh, et al.
ACS Applied Materials & Interfaces (2017) Vol. 9, Iss. 28, pp. 24126-24139
Open Access | Times Cited: 129
Nano-carrier enabled drug delivery systems for nose to brain targeting for the treatment of neurodegenerative disorders
Shadab Md, Subrat K. Bhattmisra, Farrukh Zeeshan, et al.
Journal of Drug Delivery Science and Technology (2017) Vol. 43, pp. 295-310
Closed Access | Times Cited: 120
Neurotheranostics as personalized medicines
Bhavesh D. Kevadiya, Brendan M. Ottemann, Midhun Ben Thomas, et al.
Advanced Drug Delivery Reviews (2018) Vol. 148, pp. 252-289
Open Access | Times Cited: 96
PLGA-Based Nanoparticles for Neuroprotective Drug Delivery in Neurodegenerative Diseases
Anthony Cunha, Alexandra Gaubert, Laurent Latxague, et al.
Pharmaceutics (2021) Vol. 13, Iss. 7, pp. 1042-1042
Open Access | Times Cited: 77
A Reevaluation of Chitosan-Decorated Nanoparticles to Cross the Blood-Brain Barrier
Hernán Cortés, Sergio Alcalá-Alcalá, Isaac H. Caballero‐Florán, et al.
Membranes (2020) Vol. 10, Iss. 9, pp. 212-212
Open Access | Times Cited: 73
Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation
Javad Sharifi‐Rad, Simona Rapposelli, Simona Sestito, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 9, pp. 1515-1515
Open Access | Times Cited: 48
Targeted therapy of breast tumor by PLGA-based nanostructures: The versatile function in doxorubicin delivery
Tenzin Sonam Dongsar, Tenzin Tsering Dongsar, Nagashekhara Molugulu, et al.
Environmental Research (2023) Vol. 233, pp. 116455-116455
Closed Access | Times Cited: 26
Fullerenes: Historical background, novel biological activities versus possible health risks
Casandra Pesado-Gómez, Juan S. Serrano‐García, Andrés Amaya-Flórez, et al.
Coordination Chemistry Reviews (2023) Vol. 501, pp. 215550-215550
Closed Access | Times Cited: 24
Advancements in nose-to-brain drug targeting for Alzheimer’s disease: a review of nanocarriers and clinical insights
Kumari Komal, Rashmi Ghosh, Debayan Sil, et al.
Inflammopharmacology (2025)
Closed Access | Times Cited: 1
Chemically exfoliated WS2 nanosheets efficiently inhibit amyloid β-peptide aggregation and can be used for photothermal treatment of Alzheimer’s disease
Meng Li, Andong Zhao, Kai Dong, et al.
Nano Research (2015) Vol. 8, Iss. 10, pp. 3216-3227
Closed Access | Times Cited: 84
In vitro and in vivo evaluation of levodopa-loaded nanoparticles for nose to brain delivery
Sema Arısoy, Özgün SAYINER, Tansel Çomoğlu, et al.
Pharmaceutical Development and Technology (2020) Vol. 25, Iss. 6, pp. 735-747
Closed Access | Times Cited: 66
Functional single-walled carbon nanotubes ‘CAR’ for targeting dopamine delivery into the brain of parkinsonian mice
Qing Guo, Huihui You, Xu Yang, et al.
Nanoscale (2017) Vol. 9, Iss. 30, pp. 10832-10845
Closed Access | Times Cited: 63
Biodegradable Nanoparticles Loaded with Levodopa and Curcumin for Treatment of Parkinson’s Disease
Bassam Felipe Mogharbel, Marco André Cardoso, Ana Carolina Irioda, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2811-2811
Open Access | Times Cited: 28
PLGA nanomedical consignation: A novel approach for the management of prostate cancer
Tenzin Sonam Dongsar, Tenzin Tsering Dongsar, Garima Gupta, et al.
International Journal of Pharmaceutics (2024) Vol. 652, pp. 123808-123808
Closed Access | Times Cited: 7
Anti-Parkinson potential of hesperetin nanoparticles: in vivo and in silico investigations
Praveen Kumar Pasala, Prasanth DSNBK, Mithun Rudrapal, et al.
Natural Product Research (2024), pp. 1-10
Open Access | Times Cited: 6
Brain aging and Parkinson’s disease: New therapeutic approaches using drug delivery systems
Carlos Rodríguez‐Nogales, Elisa Garbayo, Mar Carmona‐Abellán, et al.
Maturitas (2015) Vol. 84, pp. 25-31
Closed Access | Times Cited: 52
The blood–brain barrier and beyond: Nano-based neuropharmacology and the role of extracellular matrix
Petra Henrich‐Noack, Dragana Nikitovic, Monica Neagu, et al.
Nanomedicine Nanotechnology Biology and Medicine (2019) Vol. 17, pp. 359-379
Closed Access | Times Cited: 51
Page 1 - Next Page

Scroll to top